Thank you for your questions Ludger.
In part, the Commission told me that in in both Regulations [(EU) 2017/745 (Article 2(33)) and (EU) 2017/746 (Article 2(26)], "importer" is defined as "any natural or legal person established within the Union that places a device from a third country on the Union market". Therefore, if a manufacturer established outside the EU places a device on the EU market directly to a user, in such a case there is no importer, as there is no person established within the Union placing a device from a third country.
The UK MDR contains certain obligations for the healthcare professional end-user if the device is a custom-made device. I only mentioned that to assure it was clear that, even if the direct-sale end-user is not an importer, such end-user can still have certain regulatory obligations (though not importer obligations) when the subject device is a custom-made device. In other words, I mentioned that so it is clear that, just because an end-user is exempt from importer obligations, it remains that they can still be subject to certain other obligations. Didn't mean to confuse the importer issue.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright by ComplianceAcuity, Inc. All rights reserved.
------------------------------
Original Message:
Sent: 25-Jan-2024 02:17
From: Ludger Moeller
Subject: UK importer & hospital/clinic end users
Dear Anonymous,
Thank you for forwarding your questions. Kevin provided the correct answer-no MDR article 13 Importer requirements for the end user. However, it's worth noting that there may be local regulations for products sold directly to consumers in certain countries. Some products may require pharmacy involvement. It is recommended to check for any restrictions on direct sales to patients for a Class IIb implantable product, considering local distribution requirements. For example, in Germany, initially, COVID tests could only be performed by professionals due to specific objectives, but this changed during the pandemic. This illustrates local variations in distribution requirements, distinct from CE Marking requirements, and these can differ from country to country. Additionally, reimbursement policies may impact product distribution.
As I write this, it occurred to me that you might be referring to an Annex XVI product. I find it interesting, and I cannot imagine there would be any restrictions, but please share if there are any specific considerations in this context.
Dera Kevin,
You have nicely outlined that the Importer requirements, according to Article 13, do not apply to the end user, whether it is a healthcare provider, laboratory (for IVDs), or the patient himself.
Thank you for sharing your information retrieved directly from the Commission directly. Would you be able to share the actual feedback? Certainly, respecting GDPR, the name may be deleted.
I do not understand the last comment. Custom-made device. If I am a patient and I change my medical device to my needs, what should I do? Look at the MDR?
------------------------------
Ludger Moeller
President, MDSS GmbH
l.moeller@mdssar.com
Original Message:
Sent: 24-Jan-2024 11:14
From: Kevin Randall
Subject: UK importer & hospital/clinic end users
Generally speaking, end users are not considered to be importers. This is the same for the UK and the MDD/MDR alike. For example, the European Commission's Directorate-General (DG) for Health and Food Safety advised me of that interpretation regarding the MDR. For the UK, end users don't generally meet the UK regulations' trigger for "supply" or placing on the market. If instead the end user places the devices on the market or makes them further available on the market, then UK MDR regulatory obligations would ensue. As long as the end user only uses the devices for their own particular end use, then they aren't supplying or placing the devices on the market. Note that end users can however trigger certain requirements regarding custom-made devices.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright by ComplianceAcuity, Inc. All rights reserved.
Original Message:
Sent: 24-Jan-2024 05:23
From: Anonymous Member
Subject: UK importer & hospital/clinic end users
This message was posted by a user wishing to remain anonymous
Dear all,
For our UK market we are planning to launch a web shop for one of our products (class IIb implantable, currently MDD approved, but soon MDR approved) as a pilot. The product is intended for professional use. At the moment we are selling our products via an UK distributor (which is also the importer). For this pilot via a web shop, we are going to sell our products directly to hospitals/clinics and end-users.
How does this work in terms of 'importers' due to the fact all importers should be listed in the UK database. Are end-users considered as importers and is there a difference for MDD products vs MDR products?
And if end-users and considered as importers, how to manage this in case of selling to multiple end-users? Do we have to include all end-users in the UK database? This seems very impractical, is there a 'common sense way' to handle this?
Thank you